Pharsight Establishes Phoenix Center of Excellence Program
Pharsight announced that it has named five universities as Phoenix Centers of Excellence as part of its continuing collaboration with academic departments and research organizations worldwide. The Phoenix Centers of Excellence Program is a collaboration with Pharsight to enhance research and training in pharmacometrics at several academic centers. More than 350 pharmacy and medical schools worldwide currently usePharsight software for teaching and research purposes.
The five Pharsight Phoenix Centers of Excellence are:
• The University of Auckland School of Medicine, Department of Pharmacology and Clinical Pharmacology.
• The State University of New York (SUNY) at Buffalo School of Pharmacyand Pharmaceutical Sciences, Department of Pharmaceutical Sciences.
• The University of Minnesota School of Pharmacy, Department of Experimental and Clinical Pharmacology.
• Uppsala University Faculty of Pharmacy, Department of Pharmaceutical Biosciences, Division of Pharmacokinetics and Drug Therapy.
• The University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics.
The Centers of Excellence will collaborate with Pharsight to promote excellence in pharmacometrics through topical lectures and webinars on the application of model-based approaches to improve drug development knowledge and decisionmaking. The Centers of Excellence will also participate in other activities designed to recognize important contributions to the field of pharmacometrics through expanded access to Pharsight software, including Phoenix®, Pharsight’s desktop software platform for pharmacokinetic and pharmacodynamic (PKPD) data analysis and modeling.
“Our deeper collaboration with these top academic centers will support their pivotal role in the training of tomorrow’s pharmacometrics practitioners, of which there is a widely recognized global shortage. We are pleased to share Pharsight’s tools with these institutions and look forward to further collaborations to strengthen the interdisciplinary field of model-based drug development,"said Daniel Weiner, Ph.D., Senior Vice President and Chief Technology Officer of Pharsight.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
